Please note: NECA will be closed from Friday 22nd December, reopening on Monday 8th January

Advocacy

NeuroEndocrine Cancer Australia Celebrates Groundbreaking PBS Recommendation of Life-Changing Treatment for Von Hippel-Lindau (VHL) Patients.

August 23, 2024

CanForum 2024 – A Rare Cancer Moonshot

August 21, 2024

NeuroEndocrine Cancer Australia (NECA) receives inaugural Government Grant for Specialist Support Services.

July 2, 2024

Senate Inquiry Report Released with 41 Recommendations

May 27, 2024

Sign this life-changing petition to place Belzutifan on the PBS in Australia

March 20, 2024

NECA Team’s Advocacy Efforts Extend to 13 Industry Boards and working groups for Neuroendocrine Cancer Patients

February 23, 2024

Tamworth local Ryan Harding advocates for VHL patients to have access to Belzutifan

February 23, 2024

NET Patient Rob Hammond speaks at the Senate Inquiry hearing in Tasmania

February 20, 2024

NECA presents alongside Peter MacCallum Cancer Centre at the Senate Inquiry

February 1, 2024

Celebrating one year of the Optimal Care Pathway for people with NETs

January 24, 2024

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Categories